Electrochemical-Based Biosensors: New Diagnosis Platforms for Cardiovascular Disease Publisher Pubmed



Yousefi F¹ ; Movahedpour A^{2, 3} ; Shabaninejad Z^{4, 5} ; Ghasemi Y^{2, 5, 6} ; Rabbani S⁷ ; Sobnaninasab A⁸ ; Mohammadi S^{9, 10} ; Hajimoradi B¹¹ ; Rezaei S¹² ; Savardashtaki A^{2, 5} ; Mazoochi M¹³ ; Mirzaei H¹⁴ Show Affiliations
Source: Current Medicinal Chemistry Published:2020

Abstract

One of the major reasons for mortality throughout the world is cardiovascular diseases. Therefore, bio-markers of cardiovascular disease are of high importance to diagnose and manage procedure. Detecting biomarkers provided a promising procedure in developing bio-sensors. Fast, selective, portable, accurate, inexpensive, and sensitive biomarker sensing instruments will be necessary for detecting and predicting diseases. One of the cardiac biomarkers may be ordered as C-reactive proteins, lipoprotein-linked phospho-lipase, troponin I or T, myoglobin, interleukin-6, interleukin-1, tumor necrosis factor alpha, LDL and myeloperoxidase. The biomarkers are applied to anticipate cardio-vascular illnesses. Initial diagnoses of these diseases are possible by several techniques; however, they are laborious and need costly apparatus. Current researches designed various bio-sensors for resolving the respective issues. Electrochemical instruments and the proposed bio-sensors are preferred over other methods due to its inexpensiveness, mobility, reliability, repeatability. The present review comprehensively dealt with detecting biomarkers of cardiovascular disease through electro-chemical techniques. © 2020 Bentham Science Publishers.